Ishikawa H - Search Results

1

Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.

Ichikawa T, Nakao K, Nakata K, Yamashita M, Hamasaki K, Shigeno M, Abiru S, Ishikawa H, Ishii N, Eguchi K. Ichikawa T, et al. Among authors: ishikawa h. Biochem Biophys Res Commun. 2002 Jun 7;294(2):414-22. doi: 10.1016/S0006-291X(02)00502-8. Biochem Biophys Res Commun. 2002. PMID: 12051728

2

Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.

Arima T, Nakao K, Nakata K, Ishikawa H, Ichikawa T, Hamasaki K, Ishii N, Eguchi K. Arima T, et al. Among authors: ishikawa h. Int J Mol Med. 2002 Apr;9(4):397-400. Int J Mol Med. 2002. PMID: 11891535

3

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.

Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, Eguchi K. Abiru S, et al. Among authors: ishikawa h. Hepatology. 2002 May;35(5):1117-24. doi: 10.1053/jhep.2002.32676. Hepatology. 2002. PMID: 11981761

4

p48 Overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells.

Tamada Y, Nakao K, Nagayama Y, Nakata K, Ichikawa T, Kawamata Y, Ishikawa H, Hamasaki K, Eguchi K, Ishii N. Tamada Y, et al. Among authors: ishikawa h. J Hepatol. 2002 Oct;37(4):493-9. doi: 10.1016/s0168-8278(02)00232-5. J Hepatol. 2002. PMID: 12217603

5

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.

Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K. Shigeno M, et al. Among authors: ishikawa h. Oncogene. 2003 Mar 20;22(11):1653-62. doi: 10.1038/sj.onc.1206139. Oncogene. 2003. PMID: 12642868

6

Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells.

Ohata K, Ichikawa T, Nakao K, Shigeno M, Nishimura D, Ishikawa H, Hamasaki K, Eguchi K. Ohata K, et al. Among authors: ishikawa h. FEBS Lett. 2003 Oct 23;553(3):304-8. doi: 10.1016/s0014-5793(03)01034-2. FEBS Lett. 2003. PMID: 14572641 Free article.

7

Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo.

Yanagi K, Nagayama Y, Nakao K, Saeki A, Matsumoto K, Ichikawa T, Ishikawa H, Hamasaki K, Ishii N, Eguchi K. Yanagi K, et al. Among authors: ishikawa h. Int J Oncol. 2003 Feb;22(2):345-51. Int J Oncol. 2003. PMID: 12527933

8

Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.

Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K. Ishikawa H, et al. Hepatology. 2003 Mar;37(3):696-704. doi: 10.1053/jhep.2003.50077. Hepatology. 2003. PMID: 12601367

9

Short interfering RNA-directed inhibition of hepatitis B virus replication.

Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K. Hamasaki K, et al. Among authors: ishikawa h. FEBS Lett. 2003 May 22;543(1-3):51-4. doi: 10.1016/s0014-5793(03)00400-9. FEBS Lett. 2003. PMID: 12753904 Free article.

10

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K. Ohata K, et al. Among authors: ishikawa h. Cancer. 2003 Jun 15;97(12):3036-43. doi: 10.1002/cncr.11427. Cancer. 2003. PMID: 12784339 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,512 results

Search Page

Filters